The xGNN4MI framework achieved an AUC of 0.86 for diagnostic superclass classification and 0.92 for myocardial infarction localization, while identifying clinically relevant ECG leads.
Does the xGNN4MI framework provide interpretable and accurate cardiovascular disease classification and myocardial infarction localization from 12-lead ECGs?
The xGNN4MI framework provides an interpretable graph neural network approach for 12-lead ECG classification, enabling systematic comparison of AI decision-making with established clinical knowledge.
Abstract The clinical deployment of artificial intelligence (AI) solutions for assessing cardiovascular disease (CVD) risk in 12-lead electrocardiography (ECG) is hindered by limitations in interpretability and explainability. To address this, we present xGNN4MI, an open-source framework for graph neural networks (GNNs) in ECG modeling for interpretable CVD prediction. Our framework facilitates modeling clinically relevant spatial relationships between ECG leads and their temporal dynamics. We integrated explainable AI (XAI) and developed a task-specific XAI evaluation and visualization workflow to identify ECG leads crucial to the model’s decision-making process, enabling a systematic comparison with established clinical knowledge. We evaluated xGNN4MI on two challenging tasks: diagnostic superclass classification and localization of myocardial infarction. Our findings show that the interpretable ECG-GNN models demonstrate good performance across the tasks. XAI analysis revealed clinically meaningful training effects, such as differentiating between anteroseptal and inferior myocardial infarction. Our work demonstrates the potential of ECG-GNNs for providing trustworthy and interpretable AI-based CVD diagnosis.
Mäurer et al. (Fri,) conducted a other in Cardiovascular disease (Myocardial Infarction) (n=15,895). xGNN4MI (Graph Neural Network) was evaluated on Diagnostic superclass classification (AUC). The xGNN4MI framework achieved an AUC of 0.86 for diagnostic superclass classification and 0.92 for myocardial infarction localization, while identifying clinically relevant ECG leads.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: